Astronauts finish up spacewalk No. 2
Spacewalking astronauts performed more repair work on a jammed joint at the international space station on Thursday, keeping a tight grip on all their tools so nothing would get away this time.
New BlackBerry is good iPhone challenger
Review: BlackBerry fans can rejoice: the Storm, Research In Motion's first all-touchscreen Blackberry will make even iPhone users salivate just a little bit over some of the features of this very slick and sophisticated smartphone.
Grass lawns shrink in Calif. drought
California's ever-growing population and the threat of a prolonged drought could kill the concept of the traditional lush lawn in the Golden State.
Jobless claims jump to 16-year high
New claims for unemployment benefits jumped last week to a 16-year high, the Labor Department said Thursday, providing more evidence of a rapidly weakening job market.
Napolitano up for Homeland Security
An early Barack Obama supporter from the southwestern part of the country, the former Arizona attorney general is a leading contender for the job of secretary of homeland security.
Oil hits 3-year low; gas at $2 in 23 states
Oil prices on hit levels not seen in more than three years and retail gas prices are now below $2 across nearly half of the country on dour reports suggesting an economic pullback.
End of an era: The Boss' reign is officially over
George Steinbrenner's 35-year reign as boss of the New York Yankees ended Thursday when he passed control of the New York Yankees to his youngest son, Hal.
Starvation stalks children in Haiti
At least 26 severely malnourished children have died in recent days in Haiti, and aid groups fear many more deaths unless more help comes quickly to this impoverished Caribbean country.
Analysis: States fail to police Amber Alerts
Despite a federal law meant to create a uniform system, an AP review shows wide variations in what triggers Amber Alerts from one state to the next.
EpiPens: life-saving kid accessory
As allergies to peanuts, milk, eggs and gluten have risen, a cult-like following has emerged around the EpiPen, a single-shot of medication that can halt a potentially deadly reaction.
